1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Activation of immune responses against the basement membrane component collagen type IV does not affect the development of atherosclerosis in ApoE-deficient mice
(
- Contribution to journal › Article
- 2018
-
Mark
Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice
(
- Contribution to journal › Article
- 2015
-
Mark
IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.
(
- Contribution to journal › Article
-
Mark
Increased aldehyde-modification of collagen type IV in symptomatic plaques - A possible cause of endothelial dysfunction.
(
- Contribution to journal › Article
- 2013
-
Mark
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.
(
- Contribution to journal › Article
- 2012
-
Mark
Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr(-/-) Mice Compared to Nondiabetic LDLr(-/-) Mice.
(
- Contribution to journal › Article
- 2011
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
(
- Contribution to journal › Article
- 2010
-
Mark
Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe(-/-) mice.
(
- Contribution to journal › Article
- 2009
-
Mark
Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
(
- Contribution to journal › Article